Invesco Ltd. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 75 filers reported holding SEELOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$28,000
-49.1%
32,901
-2.4%
0.00%
Q4 2021$55,000
-20.3%
33,718
+17.5%
0.00%
Q3 2021$69,000
+27.8%
28,691
+41.3%
0.00%
Q2 2021$54,000
-99.7%
20,304
-99.4%
0.00%
-100.0%
Q1 2021$17,287,0003,464,2590.01%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Uniplan Investment Counsel, Inc. 2,033,020$1,904,0000.13%
1492 Capital Management LLC 150,000$141,0000.11%
Spark Investment Management LLC 13,100$12,0000.02%
ARDSLEY ADVISORY PARTNERS LP 80,000$75,0000.01%
GSA CAPITAL PARTNERS LLP 27,437$26,0000.00%
WealthPLAN Partners, LLC 20,000$18,0000.00%
CIBC WORLD MARKET INC. 500,000$468,0000.00%
CAPITAL COUNSEL LLC/NY 10,000$9,0000.00%
J.W. COLE ADVISORS, INC. 10,000$9,0000.00%
Renaissance Technologies 591,086$554,0000.00%
View complete list of SEELOS THERAPEUTICS INC shareholders